SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-11-055691
Filing Date
2011-11-10
Accepted
2011-11-10 12:38:57
Documents
2
Period of Report
2011-11-02

Document Format Files

Seq Description Document Type Size
1 GOLDBERG FORM 3 rrd324681.html 3  
1 GOLDBERG FORM 3 rrd324681.xml 3 6624
2 MARK ALAN GOLDBERG POA rrd290900_329176.htm EX-24.POA 2940
  Complete submission text file 0001181431-11-055691.txt   11035
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421
Business Address
Goldberg Mark Alan (Reporting) CIK: 0001532475 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23155 | Film No.: 111194148